Northern Trust
HUMA icon

Northern Trust’s Humacyte HUMA Stock Holding History

Northern Trust’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Sell
456,473
-767,435
-63% -$711K ﹤0.01% 3757
2026
Q1 		$743K Buy
1,223,908
+76,998
+7% +$80K ﹤0.01% 3461
2025
Q4 		$1.1M Buy
1,146,910
+115,454
+11% +$163K ﹤0.01% 3324
2025
Q3 		$1.79M Sell
1,031,456
-11,185
-1% -$21.9K ﹤0.01% 3100
2025
Q2 		$2.18M Buy
1,042,641
+117,246
+13% +$225K ﹤0.01% 2936
2025
Q1 		$1.58M Buy
925,395
+24,201
+3% +$90.9K ﹤0.01% 3044
2024
Q4 		$4.55M Buy
901,194
+92,708
+11% +$459K ﹤0.01% 2560
2024
Q3 		$4.4M Buy
808,486
+236,024
+41% +$1.56M ﹤0.01% 2561
2024
Q2 		$2.75M Buy
572,462
+22,717
+4% +$118K ﹤0.01% 2732
2024
Q1 		$1.71M Sell
549,745
-15,362
-3% -$51.7K ﹤0.01% 3048
2023
Q4 		$1.6M Buy
565,107
+46,521
+9% +$119K ﹤0.01% 3110
2023
Q3 		$1.52M Buy
518,586
+18,578
+4% +$61.5K ﹤0.01% 3083
2023
Q2 		$1.43M Buy
500,008
+14,171
+3% +$51.1K ﹤0.01% 3203
2023
Q1 		$1.5M Sell
485,837
-24,065
-5% -$68.4K ﹤0.01% 3068
2022
Q4 		$1.08M Buy
509,902
+274,260
+116% +$833K ﹤0.01% 3229
2022
Q3 		$769K Sell
235,642
-6,747
-3% -$25.9K ﹤0.01% 3377
2022
Q2 		$777K Buy
242,389
+120,300
+99% +$669K ﹤0.01% 3406
2022
Q1 		$862K Sell
122,089
-2,287
-2% -$13.3K ﹤0.01% 3497
2021
Q4 		$901K Buy
+124,376
New +$1.23M ﹤0.01% 3586

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust's HUMA Position: Q2 2026 in Review

Northern Trust reduced its Humacyte (HUMA) stake by 63% in Q2 2026, selling an estimated $711K and leaving 456,473 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #3757.

Northern Trust first reported a position in HUMA in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.55M in Q4 2024. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Northern Trust held 456,473 shares of Humacyte worth $356K as of Q2 2026.
  • Northern Trust sold 767,435 Humacyte shares in Q2 2026, an estimated $711K.
  • Humacyte made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3757 holding.
  • Northern Trust first reported a position in Humacyte in Q4 2021 and has held it in 19 quarters since.
  • Northern Trust's Humacyte position peaked at $4.55M in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.